Non-cystic fibrosis bronchiectasis

Journal of Paediatrics and Child Health

Volumn 48, Issue 5, 2012, Pages 382-388

  Al Subie, Haya ^a   Fitzgerald, Dominic A ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

bronchiectasis; investigation; pathogenesis; treatment

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BRONCHODILATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE; MANNITOL; MUCOLYTIC AGENT; SODIUM CHLORIDE;

BRONCHIECTASIS; BRONCHODILATATION; BRONCHOSPASM; CILIARY DYSKINESIA; CLINICAL FEATURE; COUGHING; CYSTIC FIBROSIS; DISEASE ASSOCIATION; EXERCISE TOLERANCE; HEALTH CARE ACCESS; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HYGIENE; IMMUNE DEFICIENCY; IMMUNE FUNCTION TEST; IMMUNIZATION; LUNG CLEARANCE; NONCYSTIC FIBROSIS BRONCHIECTASIS; NONHUMAN; NUTRITIONAL STATUS; PATHOGENESIS; PEDIATRICIAN; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PRIORITY JOURNAL; PULMONARY ASPIRATION; QUALITY OF LIFE; REVIEW; SPIROMETRY; SPUTUM CULTURE; SWEAT TEST; THORAX RADIOGRAPHY; TUBERCULIN TEST;

AUSTRALIA; BRONCHIECTASIS; CHILD; DIAGNOSIS, DIFFERENTIAL; HUMANS; NEW ZEALAND;

EID: 84861115302     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2010.01871.x     Document Type: Review

References (61)

1. Laennec RTH,. Treatise on Diseases of Chest and Mediate Auscultation, 4th edn [1819]. Trans. Forbes J. London: Longman, 1834.
2. Field CE,. Bronchiectasis in childhood: I. Clinical survey of 160 cases. Pediatrics 1949; 4: 21-46.
3. Lewiston NJ,. Bronchiectasis in childhood. Pediatr. Clin. North Am. 1984; 31: 865-78. (Pubitemid 14068980)
4. Dagli E,. Non-cystic fibrosis bronchiectasis. Paediatr. Respir. Rev. 2000; 1: 64-70.
5. Eastham KM, Fall KJ, Mitchell L, Spencer DA,. The need to redefine non-cystic fibrosis bronchiectasis in childhood. Thorax 2004; 59: 324-7. (Pubitemid 38496751)
6. Gaillard EA, Carty H, Heaf D, Smyth RL,. Reversible bronchial dilatation in children: comparison of serial high-resolution computer tomography scans of the lungs. Eur. J. Radiol. 2003; 47: 215-20. (Pubitemid 36970082)
7. Chang AB, Redding GJ, Everard ML,. Chronic wet cough: protracted bronchitis, chronic suppurative lung disease and bronchiectasis. Pediatr. Pulmonol. 2008; 43: 519-31. (Pubitemid 351813004)
8. Chang AB, Landau LI, van Asperen PP, et al,. Cough in children: definitions and clinical evaluation. Thoracic Society of Australia and New Zealand Position Statement. Med. J. Aust. 2006; 184: 398-403.
9. Brenner DJ,. Estimating cancer risks from pediatric CT: going from the qualitative to the quantitative. Pediatr. Radiol. 2002; 32: 228-31. (Pubitemid 36075689)
10. Fall A, Spencer D,. Paediatric bronchiectasis in Europe: what now and where next. Paediatr. Respir. Rev. 2006; 7: 268-74. (Pubitemid 44689276)
11. Byrnes C,. Non cystic fibrosis bronchiectasis. Pediatr. Respir. Rev. 2006; 7S: S255-7. (Pubitemid 43906299)
12. Nikolaizik WH, Warner JO,. Aetiology of chronic suppurative lung disease. Arch. Dis. Child. 1994; 70: 141-2. (Pubitemid 24088971)
13. Sayajakangas O, Keistinen T, Tuuponen TO, et al,. Evaluation of the incidence and age distribution of bronchiectasis from the Finnish hospital discharge register. Cent. Eur. J. Public Health 1998; 6: 235-7.
14. Twiss J, Metcalfe R, Edwards E, et al,. New Zealand national incidence of bronchiectasis 'too high' for a developed country. Arch. Dis. Child. 2005; 90: 737-40. (Pubitemid 40922509)
15. Chang AB, Masel JP, Boyce NC, Wheaton G, Torzillo PJ,. Non-CF bronchiectasis-clinical and HRCT evaluation. Pediatr. Pulmonol. 2003; 35: 477-83. (Pubitemid 36629068)
16. Singleton RJ, Morris A, Redding G, et al,. Bronchiectasis in Alaska Native children: causes and clinical courses. Pediatr. Pulmonol. 2000; 29: 182-7. (Pubitemid 30141794)
17. Edwards EA, Metcalfe R, Milne DG, Thompson J, Byrnes CA,. Retrospective review of children presenting with non-cystic fibrosis bronchiectasis: HRCT features and clinical relationships. Pediatr. Pulmonol. 2003; 36: 87-93. (Pubitemid 36959546)
18. Karakoc GB, Yilmaz M, Altintas DU, Kendiril SG,. Bronchiectasis: still a problem. Pediatr. Pulmonol. 2001; 32: 175-8. (Pubitemid 32730256)
19. Marostica PJC, Fischer GB,. Non cystic fibrosis bronchiectasis: a perspective from South America. Paediatr. Respir. Rev. 2006; 7: 275-80. (Pubitemid 44689273)
20. Cole PJ,. Inflammation: a two edged sword-the model of bronchiectasis. Eur. J. Respir. Dis. Suppl. 1986; 147: 6-15. (Pubitemid 16017382)
21. Barker AF,. Bronchiectasis. N. Engl. J. Med. 2002; 346: 1383-93. (Pubitemid 34754612)
22. Gaga M, Bentley AM, Humbert M, et al,. Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. Thorax 1998; 53: 685-91. (Pubitemid 28378485)
23. Tsang KW, Chan K, Ho P, et al,. Sputum elastase in steady-state bronchiectasis. Chest 2000; 117: 420-6. (Pubitemid 30111593)
24. Boyton RJ,. Bronchiectasis. Medicine 2008; 36: 315-20. (Pubitemid 351699662)
25. Regamey N, Ochs M, Hilliard TN, et al,. Increased airway smooth muscle mass in children with asthma, cystic fibrosis and non-cystic fibrosis bronchiectasis. Am. J. Respir. Crit. Care Med. 2008; 177: 837-43. (Pubitemid 351600661)
26. Li AM, Sonappa S, Lex C, et al,. Non-CF bronchiectasis: does knowing the aetiology lead to changes in management? Eur. Respir. J. 2005; 26: 8-14. (Pubitemid 40945925)
27. King P, Holdsworth S, Freezer N, Holmes P,. Bronchiectasis. Intern. Med. J. 2006; 36: 729-37. (Pubitemid 44563435)
28. Haciibrahimoglu G, Fazlioglu M, Olcmen A, et al,. Surgical management of childhood bronchiectasis due to infectious diseases. J. Thorac. Cardiovasc. Surg. 2004; 127: 1361-5. (Pubitemid 38560598)
29. Gomes Neto A, Medeiros ML, Gifoni JMM,. Localized and multi-segmental bronchiectasis: clinical-epidemiological profile and surgical treatment results in 67 cases. J. Bras Pneumol. 2000; 27: 1-6.
30. Sancho LMM, Paschoalini MS, Vicentini FC, et al,. Surgical treatment of bronchiectasis. J. Bras Pneumol. 1996; 22: 241-6.
31. Reid LM,. Reduction in bronchial subdivision in bronchiectasis. Thorax 1950; 5: 233-47.
32. Hansell DM,. Bronchiectasis. Radiol. Clin. North Am. 1998; 36: 107-28. (Pubitemid 28079678)
33. Chang AB, Eastburn MM, Gaffney J, et al,. Cough quality in children: a comparison of subjective vs bronchoscopic findings. Respir. Res. 2005; 6: 3-8.
34. Karadag B, Karakoc F, Ersu R, Kut A, Bakac S, Dagli E,. Non-cystic fibrosis bronchiectasis in children: a persisting problem in developing countries. Respiration 2005; 72: 233-8. (Pubitemid 40981080)
35. van der Bruggen-Bogaarts BAHA, van der Bruggen HMJG, van Waes PFGM, Lammers JWJ,. Screening for bronchiectasis. A comparative study between chest radiography and high-resolution CT. Chest 1996; 109: 608-11. (Pubitemid 26086922)
36. Reiff DB, Wells AU, Carr DH, Cole PJ, Hansell DM,. CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types. Am. J. Roentgenol. 1995; 165: 261-7.
37. Cartier Y, Kavanagh PV, Johkoh T, Mason AC, Muller NL,. Bronchiectasis: accuracy of high resolution CT in the differentiation of specific diseases. Am. J. Roentgenol. 1999; 173: 47-52. (Pubitemid 29291088)
38. Fitzgerald DA, Follett J, van Asperen PP,. Assessing and managing lung disease and sleep disordered breathing in children with cerebral palsy. Paediatr. Respir. Rev. 2009; 10: 18-24.
39. Marchant JM, Masel JP, Dickenson FL, Masters IB, Chang AB,. Application of chest high-resolution computer tomography in young children with cystic fibrosis. Pediatr. Pulmonol. 2001; 31: 24-9. (Pubitemid 32154737)
40. Angrill J, Augusti C, de Celis R, et al,. Bacterial colonization in patients with bronchiectasis: microbiological pattern and risk factors. Thorax 2002; 57: 15-9. (Pubitemid 34081538)
41. Evans DJ, Greenstone M,. Long term antibiotics in the management of bronchiectasis-do they improve outcome? Respir. Med. 2003; 97: 851-8. (Pubitemid 36763899)
42. Evans SA, Turner SM, Bosch BJ, et al,. Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa. Eur. Respir. J. 1996; 9: 1601-4. (Pubitemid 26271139)
43. Miszkiel KA, Wells AU, Rubens MB, Cole PJ, Hansell DM,. Effects of airway infection by Pseudomonas aeruginosa: a computerised tomographic study. Thorax 1997; 52: 260-4. (Pubitemid 27128177)
44. Sirmali M, Karasu S, Turut H, et al,. Surgical management of bronchiectasis in childhood. Eur. J. Cardiothorac. Surg. 2007; 31: 120-3. (Pubitemid 44880768)
45. Rubin BK,. Overview of cystic fibrosis and non-CF bronchiectasis. Semin. Respir. Crit. Care Med. 2003; 24: 619-27. (Pubitemid 38036757)
46. Rubin BK,. Aerosolized antibiotics for non-cystic fibrosis bronchiectasis. J. Aerosol Med. 2008; 21: 1-6.
47. Twiss J, Byrnes C, Johnson R, Holland D,. Nebulised gentamicin-suitable for childhood bronchiectasis. Int. J. Pharm. 2005; 295: 113-9. (Pubitemid 40558794)
48. Ramsay B, Pepe MS, Quan JM, et al,. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N. Engl. J. Med. 1999; 340: 23-30. (Pubitemid 29024680)
49. Wills P, Greenstone M,. Inhaled hyperosmolar agents for bronchiectasis. Cochrane Database Syst. Rev. 2006; 2: CD002996.
50. Anwar GA, Bourke SC, Afolabi G, Middleton P, Ward C, Rutherford RM,. Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis. Respir. Med. 2008; 102: 1494-6.
51. Rosen MJ,. Chronic cough due to bronchiectasis: ACCP evidence-based clinical practice guidelines. Chest 2006; 129: 122S-31S. (Pubitemid 43265213)
52. Tsang KWT, Ho PL, Lam WK, et al,. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. Am. J. Respir. Crit. Care Med. 1998; 158: 723-7. (Pubitemid 28449432)
53. Tsang KW, Tan KC, Ho PL, et al,. Inhaled fluticasone in bronchiectasis: a 12 month study. Thorax 2005; 60: 239-43. (Pubitemid 40380285)
54. Martinez-Garcia MA, Perpina-Tordera M, Roman-Sanchez P, Soler-Cataluna JJ,. Inhaled steroids improve quality of life in patients with steady state bronchiectasis. Respir. Med. 2006; 100: 1623-32. (Pubitemid 44089352)
55. Kellett F, Redfern J, McL Niven R,. Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis. Respir. Med. 2005; 99: 27-31. (Pubitemid 40017380)
56. Robinson M, Davisakas E, Eberl S, et al,. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study. Eur. Respir. J. 1999; 14: 678-85. (Pubitemid 29479736)
57. Daviskas E, Anderson S, Eberl S, Kim Chan H, Bautovich G,. Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis. Am. J. Respir. Crit. Care Med. 1999; 159: 1843-8. (Pubitemid 29275053)
58. Daviskas E, Anderson SD, Gomes K, et al,. Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum. Respirology 2005; 10: 46-56. (Pubitemid 40343762)
59. Fitzgerald DA, Hilton J, Jepson B, Smith L,. A crossover, randomised trial of dornase alfa before versus after physiotherapy in cystic fibrosis. Pediatrics 2005; 116: e549-54. (Pubitemid 44542796)
60. Crockett AJ, Cranston JM, Latimer KM, Alpers JH,. Mucolytics for bronchiectasis. Cochrane Database Syst. Rev. 2001; 1: CD00128.
61. Fuchs HJ, Borowitz DS, Christiansen DH, et al,. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N. Engl. J. Med. 1994; 331: 637-42. (Pubitemid 24276863)